2-Iodo-4-Methoxychalcone Attenuates Methylglyoxal-Induced Neurotoxicity by Activation of GLP-1 Receptor and Enhancement of Neurotrophic Signal, Antioxidant Defense and Glyoxalase Pathway
This dual mechanism produces different downstream effects on brain chemistry, appetite regulation, and potentially sexual function
The 0.25mg starting dose is not a weight loss dose
With options for both injectable and oral forms, semaglutide mimics GLP-1, a natural hormone that reduces appetite and facilitates lasting weight loss
Diet Hacks That Maximise Weight Loss When Using GLP-1 Medications GLP-1 medications, such as Mounjaro (tirzepatide) and Wegovy (semaglutide), are becoming increasingly popular as weight-loss treatments
Pharmacologic approaches to glycemic treatment: Standards of Care in Diabetes2025